Login

Financial Snapshot

Revenue
TTM
$1.196B
Gross Margin
TTM
48.15%
Net Income
TTM
$121.2M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
347.07%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
1.897B
Cash
2026 Q1
P/E
TTM
20.37
Free Cash Flow
TTM
$226.4M

Stock Price

Loading...
Market Cap: $2.4702 Billion

About Green Thumb Industries Inc

Green Thumb Industries Inc (OTC: GTBIF) is a U.S. cannabis company that cultivates, manufactures, and retails cannabis products across multiple states. The company generates revenue through direct-to-consumer sales at its own retail dispensaries as well as through wholesale distribution of its branded cannabis products to third-party dispensaries. Green Thumb trades on the Canadian Securities Exchange in addition to U.S. over-the-counter markets. The 10-K filed February 25, 2026 covers the fiscal year ended December 31, 2025. The filing confirms the company is registered under Section 12(g) of the Securities Exchange Act and is not listed on a U.S. national securities exchange, consistent with federal cannabis restrictions. Beyond these structural details, the filing excerpts provided do not supply sufficient operational or financial data to characterize segment revenue, store counts, market position, leadership, or founding history.

Revenue model
The filing excerpts do not provide sufficient detail to describe the revenue model with specificity.
Products and services
The filing excerpts do not enumerate specific products, brands, or services.
Customers and end markets
The filing excerpts do not describe customer types or end markets with specificity.
Value-chain role
The filing excerpts do not provide sufficient detail to characterize Green Thumb's value-chain role.
Geographic exposure
The filing excerpts do not specify states or geographies of operation.

Source: SEC 10-K, filed 2026-02-25

Industry: Agricultural Production-Crops Peers: Pacira Biosciences Inc Catalent, Inc. CORCEPT THERAPEUTICS INC Elanco Animal Health Inc Harmony Biosciences Holdings Inc Intra-Cellular Therapies, Inc. Johnson & Johnson Organon & Co Prestige Consumer Healthcare Inc Viatris Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support